Trial
NCT01163786
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
Robert H. Lurie Cancer Center
Condition
Bronchiolitis Obliterans
Intervention
Bortezomib
Why stopped
Study was closed due to low accrual before the accrual goal was reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-10